# A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

> **NCT01347203** · PHASE1 · COMPLETED · sponsor: **Diakron Pharmaceuticals** · enrollment: 12 (estimated)

## Conditions studied

- Deep Vein Thrombosis Leg

## Interventions

- **DRUG:** DPOC-4088
- **DRUG:** DPOC-4088
- **DRUG:** DPOC-4088
- **DRUG:** DPOC-4088

## Key facts

- **NCT ID:** NCT01347203
- **Lead sponsor:** Diakron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347203, "A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01347203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*